Vanda Pharmaceuticals
VNDA
#7958
Rank
NZ$0.65 B
Marketcap
NZ$10.93
Share price
2.64%
Change (1 day)
35.25%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$71.57 Million a decrease over its 2023 earnings that were of -NZ$24.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion190.31%
2024 -NZ$71.57 Million191.43%
2023 -NZ$24.56 Million-320.45%
2022 NZ$11.13 M-84.99%
2021 NZ$74.21 M54.8%
2020 NZ$47.94 M19.42%
2019 NZ$40.14 M4.93%
2018 NZ$38.25 M-228.6%
2017 -NZ$29.75 Million-8.98%
2016 -NZ$32.69 Million-53.79%
2015 -NZ$70.73 Million-30.18%
2014 -NZ$0.11 Billion173.08%
2013 -NZ$37.1 Million-25.33%
2012 -NZ$49.68 Million163.61%
2011 -NZ$18.85 Million-221.15%
2010 NZ$15.55 M-124.53%
2009 -NZ$63.42 Million-29.44%
2008 -NZ$89.88 Million-36.2%
2007 -NZ$0.15 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.72 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.77 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.64 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.77 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.14 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.89 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.94 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA